Statistics for Safety-Driven Ocrelizumab Discontinuation Vs Continuation: Comparative Insights From MSBase
Total visits
| views | |
|---|---|
| Safety-Driven Ocrelizumab Discontinuation Vs Continuation: Comparative Insights From MSBase | 10 |
Total visits per month
| views | |
|---|---|
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 2 |
| February 2026 | 1 |
| March 2026 | 0 |
| April 2026 | 7 |
Top country views
| views | |
|---|---|
| China | 10 |